title: Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation.
abstract: OBJECTIVE
  A Pan-Canadian Practice Guideline on Screening, Assessment, and Care of Psychosocial Distress (Depression, Anxiety) in Adults With Cancer was identified for adaptation.
  
  
  METHODS
  American Society of Clinical Oncology (ASCO) has a policy and set of procedures for adapting clinical practice guidelines developed by other organizations. The guideline was reviewed for developmental rigor and content applicability.
  
  
  RESULTS
  On the basis of content review of the pan-Canadian guideline, the ASCO panel agreed that, in general, the recommendations were clear, thorough, based on the most relevant scientific evidence, and presented options that will be acceptable to patients. However, for some topics addressed in the pan-Canadian guideline, the ASCO panel formulated a set of adapted recommendations based on local context and practice beliefs of the ad hoc panel members. It is recommended that all patients with cancer be evaluated for symptoms of depression and anxiety at periodic times across the trajectory of care. Assessment should be performed using validated, published measures and procedures. Depending on levels of symptoms and supplementary information, differing treatment pathways are recommended. Failure to identify and treat anxiety and depression increases the risk for poor quality of life and potential disease-related morbidity and mortality. This guideline adaptation is part of a larger survivorship guideline series.
  
  
  CONCLUSIONS
  Although clinicians may not be able to prevent some of the chronic or late medical effects of cancer, they have a vital role in mitigating the negative emotional and behavioral sequelae. Recognizing and treating effectively those who manifest symptoms of anxiety or depression will reduce the human cost of cancer.
authors.affiliation: Barbara L. Andersen, The Ohio State University, Columbus, OH; Robert J. DeRubeis, University of Pennsylvania, Philadelphia, PA; Barry S. Berman, Broward Health Medical Center, Fort Lauderdale, FL; Jessie Gruman, Center for Advancing Health, Washington, DC; Victoria L. Champion, Indiana University, Indianapolis, IN; Mary Jane Massie, Jimmie C. Holland, Memorial Sloan-Kettering Cancer Institute, New York, NY; Ann H. Partridge, Dana Farber Cancer Institute, Boston, MA; Kate Bak and Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Julia H. Rowland, National Cancer Institute, Bethesda, MD.
authors.forename: Barbara L
authors.initials: BL
authors.lastname: Andersen
authors.affiliation: Barbara L. Andersen, The Ohio State University, Columbus, OH; Robert J. DeRubeis, University of Pennsylvania, Philadelphia, PA; Barry S. Berman, Broward Health Medical Center, Fort Lauderdale, FL; Jessie Gruman, Center for Advancing Health, Washington, DC; Victoria L. Champion, Indiana University, Indianapolis, IN; Mary Jane Massie, Jimmie C. Holland, Memorial Sloan-Kettering Cancer Institute, New York, NY; Ann H. Partridge, Dana Farber Cancer Institute, Boston, MA; Kate Bak and Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Julia H. Rowland, National Cancer Institute, Bethesda, MD.
authors.forename: Robert J
authors.initials: RJ
authors.lastname: DeRubeis
authors.affiliation: Barbara L. Andersen, The Ohio State University, Columbus, OH; Robert J. DeRubeis, University of Pennsylvania, Philadelphia, PA; Barry S. Berman, Broward Health Medical Center, Fort Lauderdale, FL; Jessie Gruman, Center for Advancing Health, Washington, DC; Victoria L. Champion, Indiana University, Indianapolis, IN; Mary Jane Massie, Jimmie C. Holland, Memorial Sloan-Kettering Cancer Institute, New York, NY; Ann H. Partridge, Dana Farber Cancer Institute, Boston, MA; Kate Bak and Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Julia H. Rowland, National Cancer Institute, Bethesda, MD.
authors.forename: Barry S
authors.initials: BS
authors.lastname: Berman
authors.affiliation: Barbara L. Andersen, The Ohio State University, Columbus, OH; Robert J. DeRubeis, University of Pennsylvania, Philadelphia, PA; Barry S. Berman, Broward Health Medical Center, Fort Lauderdale, FL; Jessie Gruman, Center for Advancing Health, Washington, DC; Victoria L. Champion, Indiana University, Indianapolis, IN; Mary Jane Massie, Jimmie C. Holland, Memorial Sloan-Kettering Cancer Institute, New York, NY; Ann H. Partridge, Dana Farber Cancer Institute, Boston, MA; Kate Bak and Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Julia H. Rowland, National Cancer Institute, Bethesda, MD.
authors.forename: Jessie
authors.initials: J
authors.lastname: Gruman
authors.affiliation: Barbara L. Andersen, The Ohio State University, Columbus, OH; Robert J. DeRubeis, University of Pennsylvania, Philadelphia, PA; Barry S. Berman, Broward Health Medical Center, Fort Lauderdale, FL; Jessie Gruman, Center for Advancing Health, Washington, DC; Victoria L. Champion, Indiana University, Indianapolis, IN; Mary Jane Massie, Jimmie C. Holland, Memorial Sloan-Kettering Cancer Institute, New York, NY; Ann H. Partridge, Dana Farber Cancer Institute, Boston, MA; Kate Bak and Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Julia H. Rowland, National Cancer Institute, Bethesda, MD.
authors.forename: Victoria L
authors.initials: VL
authors.lastname: Champion
authors.affiliation: Barbara L. Andersen, The Ohio State University, Columbus, OH; Robert J. DeRubeis, University of Pennsylvania, Philadelphia, PA; Barry S. Berman, Broward Health Medical Center, Fort Lauderdale, FL; Jessie Gruman, Center for Advancing Health, Washington, DC; Victoria L. Champion, Indiana University, Indianapolis, IN; Mary Jane Massie, Jimmie C. Holland, Memorial Sloan-Kettering Cancer Institute, New York, NY; Ann H. Partridge, Dana Farber Cancer Institute, Boston, MA; Kate Bak and Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Julia H. Rowland, National Cancer Institute, Bethesda, MD.
authors.forename: Mary Jane
authors.initials: MJ
authors.lastname: Massie
authors.affiliation: Barbara L. Andersen, The Ohio State University, Columbus, OH; Robert J. DeRubeis, University of Pennsylvania, Philadelphia, PA; Barry S. Berman, Broward Health Medical Center, Fort Lauderdale, FL; Jessie Gruman, Center for Advancing Health, Washington, DC; Victoria L. Champion, Indiana University, Indianapolis, IN; Mary Jane Massie, Jimmie C. Holland, Memorial Sloan-Kettering Cancer Institute, New York, NY; Ann H. Partridge, Dana Farber Cancer Institute, Boston, MA; Kate Bak and Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Julia H. Rowland, National Cancer Institute, Bethesda, MD.
authors.forename: Jimmie C
authors.initials: JC
authors.lastname: Holland
authors.affiliation: Barbara L. Andersen, The Ohio State University, Columbus, OH; Robert J. DeRubeis, University of Pennsylvania, Philadelphia, PA; Barry S. Berman, Broward Health Medical Center, Fort Lauderdale, FL; Jessie Gruman, Center for Advancing Health, Washington, DC; Victoria L. Champion, Indiana University, Indianapolis, IN; Mary Jane Massie, Jimmie C. Holland, Memorial Sloan-Kettering Cancer Institute, New York, NY; Ann H. Partridge, Dana Farber Cancer Institute, Boston, MA; Kate Bak and Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Julia H. Rowland, National Cancer Institute, Bethesda, MD.
authors.forename: Ann H
authors.initials: AH
authors.lastname: Partridge
authors.affiliation: Barbara L. Andersen, The Ohio State University, Columbus, OH; Robert J. DeRubeis, University of Pennsylvania, Philadelphia, PA; Barry S. Berman, Broward Health Medical Center, Fort Lauderdale, FL; Jessie Gruman, Center for Advancing Health, Washington, DC; Victoria L. Champion, Indiana University, Indianapolis, IN; Mary Jane Massie, Jimmie C. Holland, Memorial Sloan-Kettering Cancer Institute, New York, NY; Ann H. Partridge, Dana Farber Cancer Institute, Boston, MA; Kate Bak and Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Julia H. Rowland, National Cancer Institute, Bethesda, MD.
authors.forename: Kate
authors.initials: K
authors.lastname: Bak
authors.affiliation: Barbara L. Andersen, The Ohio State University, Columbus, OH; Robert J. DeRubeis, University of Pennsylvania, Philadelphia, PA; Barry S. Berman, Broward Health Medical Center, Fort Lauderdale, FL; Jessie Gruman, Center for Advancing Health, Washington, DC; Victoria L. Champion, Indiana University, Indianapolis, IN; Mary Jane Massie, Jimmie C. Holland, Memorial Sloan-Kettering Cancer Institute, New York, NY; Ann H. Partridge, Dana Farber Cancer Institute, Boston, MA; Kate Bak and Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Julia H. Rowland, National Cancer Institute, Bethesda, MD.
authors.forename: Mark R
authors.initials: MR
authors.lastname: Somerfield
authors.affiliation: Barbara L. Andersen, The Ohio State University, Columbus, OH; Robert J. DeRubeis, University of Pennsylvania, Philadelphia, PA; Barry S. Berman, Broward Health Medical Center, Fort Lauderdale, FL; Jessie Gruman, Center for Advancing Health, Washington, DC; Victoria L. Champion, Indiana University, Indianapolis, IN; Mary Jane Massie, Jimmie C. Holland, Memorial Sloan-Kettering Cancer Institute, New York, NY; Ann H. Partridge, Dana Farber Cancer Institute, Boston, MA; Kate Bak and Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Julia H. Rowland, National Cancer Institute, Bethesda, MD.
authors.forename: Julia H
authors.initials: JH
authors.lastname: Rowland
mesh_terms: D000293:Adolescent; D000328:Adult; D001007:Anxiety / Q000175:diagnosis* / Q000209:etiology / Q000523:psychology / Q000628:therapy*; D032921:Consensus; D017281:Cost of Illness; D003863:Depression / Q000175:diagnosis* / Q000209:etiology / Q000523:psychology / Q000628:therapy*; D004644:Emotions; D019317:Evidence-Based Medicine / Q000592:standards; D006801:Humans; D008495:Medical Oncology / Q000592:standards*; D009369:Neoplasms / Q000150:complications* / Q000523:psychology; D010818:Practice Patterns, Physicians' / Q000592:standards; D011237:Predictive Value of Tests; D011788:Quality of Life; D012955:Societies, Medical / Q000592:standards*; D016896:Treatment Outcome; D014481:United States; D055815:Young Adult
references.citation: PLoS One. 2012;7(1):e30955
references.pmid: 22303474
references.citation: J Pers Soc Psychol. 1993 Aug;65(2):375-90
references.pmid: 8366426
references.citation: J Clin Oncol. 2012 Oct 20;30(30):3734-45
references.pmid: 23008293
references.citation: J Clin Oncol. 2012 Oct 20;30(30):3657-64
references.pmid: 23008297
references.citation: Palliat Med. 2007 Jun;21(4):341-6
references.pmid: 17656411
references.citation: J Clin Oncol. 2012 Apr 10;30(11):1197-205
references.pmid: 22412135
references.citation: Arch Intern Med. 2006 May 22;166(10):1092-7
references.pmid: 16717171
references.citation: J Clin Oncol. 2013 Feb 10;31(5):631-40
references.pmid: 23295805
references.citation: J Clin Oncol. 2013 Feb 20;31(6):782-93
references.pmid: 23319686
references.citation: Ann Behav Med. 2008 Apr;35(2):188-97
references.pmid: 18347897
references.citation: J Aging Health. 1993 May;5(2):179-93
references.pmid: 10125443
references.citation: Br J Cancer. 2004 Jan 26;90(2):314-20
references.pmid: 14735170
references.citation: Nat Clin Pract Oncol. 2008 Aug;5(8):466-75
references.pmid: 18493231
references.citation: Clin Cancer Res. 2010 Jun 15;16(12):3270-8
references.pmid: 20530702
references.citation: Arch Gen Psychiatry. 2005 Apr;62(4):409-16
references.pmid: 15809408
references.citation: Qual Life Res. 2005 Oct;14(8):1825-33
references.pmid: 16155770
references.citation: Biol Psychiatry. 2005 Aug 1;58(3):175-89
references.pmid: 16084838
references.citation: Psychooncology. 2011 Feb;20(2):115-26
references.pmid: 20336645
references.citation: Cancer. 1998 Oct 15;83(8):1640-51
references.pmid: 9781960
references.citation: Behav Res Ther. 1990;28(6):487-95
references.pmid: 2076086
references.citation: Am J Prev Med. 2012 May;42(5):525-38
references.pmid: 22516495
references.citation: Cochrane Database Syst Rev. 2012 Jul 11;(7):CD004366
references.pmid: 22786489
references.citation: Psychiatry Res. 1985 Feb;14(2):131-42
references.pmid: 3857653
references.citation: Lancet Oncol. 2013 Jul;14(8):721-32
references.pmid: 23759376
references.citation: J Natl Cancer Inst. 1998 Jan 7;90(1):30-6
references.pmid: 9428780
references.citation: J Clin Oncol. 2013 Jun 1;31(16):1961-9
references.pmid: 23610114
references.citation: Psychosomatics. 2003 Jan-Feb;44(1):24-30
references.pmid: 12515834
references.citation: Arch Gen Psychiatry. 2005 Jun;62(6):617-27
references.pmid: 15939839
references.citation: JAMA. 2002 Jan 9;287(2):203-9
references.pmid: 11779262
references.citation: Depress Res Treat. 2012;2012:769298
references.pmid: 23133748
references.citation: Cancer. 2011 Jan 1;117(1):218-27
references.pmid: 20737537
references.citation: CMAJ. 2012 Feb 21;184(3):E191-6
references.pmid: 22184363
references.citation: Br J Soc Clin Psychol. 1967 Dec;6(4):278-96
references.pmid: 6080235
references.citation: J Clin Oncol. 2012 Oct 20;30(30):3655-6
references.pmid: 23008327
references.citation: Psychooncology. 2004 Jun;13(6):408-28
references.pmid: 15188447
references.citation: J Clin Oncol. 2012 Oct 20;30(30):3665-74
references.pmid: 23008309
references.citation: J Consult Clin Psychol. 1988 Dec;56(6):893-7
references.pmid: 3204199
references.citation: Am J Psychiatry. 2005 Jun;162(6):1171-8
references.pmid: 15930066
references.citation: Cancer. 2009 Nov 15;115(22):5349-61
references.pmid: 19753617
references.citation: Acta Psychiatr Scand. 1983 Jun;67(6):361-70
references.pmid: 6880820
references.citation: J Natl Cancer Inst. 2006 Oct 4;98(19):1416-9
references.pmid: 17018788
references.citation: Oncol Nurs Forum. 1999 Apr;26(3):593-9
references.pmid: 10214600
references.citation: Curr Opin Psychiatry. 2005 May;18(3):249-55
references.pmid: 16639148
references.citation: J Clin Oncol. 2002 Jul 15;20(14):3137-48
references.pmid: 12118028
references.citation: Cancer. 2013 Aug 1;119(15):2771-7
references.pmid: 23633409
references.citation: Arch Gen Psychiatry. 2005 Apr;62(4):417-22
references.pmid: 15809409
references.citation: Psychooncology. 2011 Jan;20(1):62-8
references.pmid: 20336636
references.citation: J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62
references.pmid: 14399272
references.citation: Psychol Bull. 2007 Jan;133(1):25-45
references.pmid: 17201569
references.citation: Postgrad Med. 1972 Dec;52(6):81-5
references.pmid: 4635613
references.citation: Brain Behav Immun. 2007 Feb;21(2):185-94
references.pmid: 16908118
references.citation: Palliat Med. 2003 Sep;17(6):509-13
references.pmid: 14526884
references.citation: Ann Behav Med. 2013 Jun;45(3):329-37
references.pmid: 23508468
references.citation: Cochrane Database Syst Rev. 2008 Apr 16;(2):CD005537
references.pmid: 18425922
references.citation: Support Care Cancer. 2003 May;11(5):278-85
references.pmid: 12720073
references.citation: J Consult Clin Psychol. 2006 Aug;74(4):658-70
references.pmid: 16881773
references.citation: J Psychiatr Res. 1982-1983;17(1):37-49
references.pmid: 7183759
references.citation: Patient Educ Couns. 2005 Feb;56(2):225-32
references.pmid: 15653253
references.citation: Health Psychol. 2004 Jan;23(1):3-15
references.pmid: 14756598
references.citation: J Clin Oncol. 2011 Feb 1;29(4):413-20
references.pmid: 21149651
references.citation: Can J Psychiatry. 2006 Jul;51(8 Suppl 2):9S-91S
references.pmid: 16933543
references.citation: Ann Fam Med. 2010 Jul-Aug;8(4):348-53
references.pmid: 20644190
references.citation: Eur J Cancer. 1997 Sep;33(10):1597-604
references.pmid: 9389921
references.citation: Psychol Med. 2010 Nov;40(11):1797-810
references.pmid: 20085667
references.citation: J Natl Cancer Inst. 2012 Jul 3;104(13):990-1004
references.pmid: 22767203
references.citation: Psychol Assess. 2003 Jun;15(2):173-83
references.pmid: 12847777
references.citation: J Pain Symptom Manage. 2002 May;23(5):406-16
references.pmid: 12007758
references.citation: J Gen Intern Med. 2001 Sep;16(9):606-13
references.pmid: 11556941
references.citation: J Clin Oncol. 2006 Nov 10;24(32):5132-7
references.pmid: 17093275
references.citation: Lancet Oncol. 2011 Feb;12(2):160-74
references.pmid: 21251875
references.citation: J Psychosom Res. 2009 Nov;67(5):369-76
references.pmid: 19837199
references.citation: J Clin Oncol. 2006 Nov 10;24(32):5101-4
references.pmid: 17093270
references.citation: N Engl J Med. 2000 May 18;342(20):1462-70
references.pmid: 10816183
references.citation: Cancer. 2008 Dec 15;113(12):3450-8
references.pmid: 19016270
references.citation: J Behav Med. 2010 Jun;33(3):250-7
references.pmid: 20204490